NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Racial Disparity in Maternal Phthalates Exposure; Association with Racial Disparity in Fetal Growth and Birth Outcomes
Published
Author(s)
Michael S. Bloom, Abby G. Wenzel, John W. Brock, Rebecca J. Wineland, Lori Cruze, Elizabeth R. Unal, Assem Jiyessova, Roger B. Newman, John Kucklick
Abstract
Background: Experimental and observational data implicate phthalates as developmental toxicants. However, few data are available to assess the maternal risks of gestational exposure by race and infant sex. Objectives: To characterize associations between maternal urinary phthalates and birth outcomes among African American and white mothers. Results: Lower z-scores were associated with higher MiBP (β=-0.28; 95%CI: -0.54, -0.02) and MMP (β=-0.31; 95%CI: -0.52, -0.09) concentrations, while MEP interacted with race (p=0.03), indicating an association among whites (β=-0.14; 95%CI: -0.28, 0.001) but not among African Americans (β=0.05; 95%CI=-0.09, 0.50). MiBP (OR=2.84; 95%CI: 1.22, 6.61) and MEOHP (OR=2.79; 95%CI: 1.05, 7.41) were associated with an overall higher SGA risk, and higher MEHP was associated with higher SGA risk (p=0.09) in whites (OR=3.22 95%CI: 0.63, 16.39) but not African Americans (OR=0.71 95%CI: 0.07, 7.11).. We detected an interaction for MEP with PTB (p=0.02); African Americans were at greater risk (OR=1.43; 95%CI: 0.96, 2.12) than whites (OR=0.62; 95%CI: 0.34, 1.13). Higher MMP was associated with an overall higher LBW risk (OR=1.90; 95%CI: 1.11, 3.25), and boys were at greater risk than girls with higher MBP (p=0.002), MiBP (p=0.02), MBzP (p=0.01), MEP (p=0.002), and MMP (p=0.09) concentrations. Discussion: Our results suggest that gestational phthalate exposure is associated with adverse maternal birth outcomes, and that the effects vary by race and infant sex.
Bloom, M.
, Wenzel, A.
, Brock, J.
, Wineland, R.
, Cruze, L.
, Unal, E.
, Jiyessova, A.
, Newman, R.
and Kucklick, J.
(2019),
Racial Disparity in Maternal Phthalates Exposure; Association with Racial Disparity in Fetal Growth and Birth Outcomes, Environmental International, [online], https://doi.org/10.1016/j.envint.2019.04.005, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=927008
(Accessed October 15, 2025)